It's a concern that this may be opening a larger black hole where we see a lot of cost shifting to people who are chronically ill.

The guidelines acknowledge racial profiling as a national concern but do nothing to stop it. The new policy guidelines provide no rights or remedies.

If they put all the MS drugs, and all the cancer drugs, and all the HIV drugs on the same cost-tier plan, they're really not discriminating against one disease group. They're discriminating against anyone who must depend on higher-cost drugs.

My concern about just having a private apology is because this happened to me it has frightened other people. It was intimidating.

We haven't changed our view that, right now, there is not a safety concern, not a public health concern.

It is a great source of concern when any of these procedures are not being followed. One is always going to find a violation here or there, but an indication that ignoring the rules is widespread practice is shocking and deplorable.